TELA TELA Bio, Inc. - Common stock
$0.67
Price · Aug 19, 2026
Fundamentals as of Aug 11, 2026
52W Range
$1–$2
11% of range
Analyst Rating
BUY
11 analysts
Price Target
$2
+214% upside
P/E (TTM)
-0.8
ROE
-501.1%
Net Profit Margin
-48.4%
TELA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.67
Market Cap
$30M
P/E (TTM)
-0.8
EPS (TTM)
$-0.83
Revenue (TTM)
$80M
Div Yield
—
ROE
-501.1%
Debt/Equity
8.8
52W Range
$1 – $2
TELA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$80M
2017-12-31
→
2025-12-31
EPS
$-0.83
2019-12-31
→
2025-12-31
Free Cash Flow
$-29M
2019-12-31
→
2025-12-31
Margins
-48.4%
2019-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
TELA
Peer Median
P/E (TTM)
-0.8
15.4
P/S (TTM)
0.4
2.8
P/B
4.7
1.6
EV / EBITDA
-1.0
—
Price / FCF
-1.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
TELA
Peer Median
Gross Margin
67.7%
31.6%
Operating Margin
-42.0%
—
Net Profit Margin
-48.4%
-49.3%
ROA
-46.2%
-54.9%
ROE
-501.1%
-98.0%
ROIC
-54.8%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
TELA
Peer Median
Debt / Equity
8.8
0.0
Current Ratio
4.2
4.7
Quick Ratio
3.4
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
TELA
Peer Median
Revenue YoY
15.8%
—
Revenue CAGR 3Y
24.7%
—
Revenue CAGR 5Y
34.5%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
TELA
Peer Median
TELA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 3 27.3%
- Buy 6 54.5%
- Hold 2 18.2%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-08-15
Median
$2.00
← Below all targets
$0.67
Low
$1.00
High
$3.00
Median target
$2.00
+198.7%
Mean target
$2.10
+213.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.01%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.20 | $-0.18 | -0.02% |
| March 31, 2026 | $-0.21 | $-0.19 | -0.02% |
| Dec. 31, 2025 | $-0.17 | $-0.19 | 0.02% |
| Sept. 30, 2025 | $-0.19 | $-0.20 | 0.01% |
| June 30, 2025 | $-0.22 | $-0.18 | -0.04% |
| March 31, 2025 | $-0.25 | $-0.20 | -0.05% |
| Dec. 31, 2024 | $-0.23 | $-0.23 | -0.00% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| UTMD | $178M | 16.1 | -5.8% | 29.3% | 9.5% | 57.1% |
| NSPR | $77M | -2.3 | 28.1% | -543.3% | -129.3% | 29.5% |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| ADVB | $15M | -4.4 | — | — | -159.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80M | $69M | $58M | $41M | $29M | $18M | $15M | $8M | |
| Gross Profit | $54M | $46M | $40M | $27M | $19M | $11M | $9M | $3M | |
| R&D Expense | $9M | $9M | $10M | $9M | $7M | $4M | $4M | $4M | |
| SG&A Expense | $16M | $15M | $15M | $14M | $12M | $10M | $6M | $5M | |
| Operating Expenses | $88M | $88M | $84M | $66M | $48M | $37M | $28M | $21M | |
| Operating Income | $-34M | $-34M | $-44M | $-39M | $-29M | $-25M | $-19M | $-18M | |
| Interest Expense | · | · | $5M | $4M | $4M | $4M | $4M | $2M | |
| Other Non-op | $1M | $1M | $3M | $-10.0K | $-228.0K | $45.0K | $351.0K | $70.0K | |
| Pretax Income | $-39M | $-38M | $-47M | $-44M | · | · | · | · | |
| Income Tax | $230.0K | $-144.0K | · | · | · | · | · | · | |
| Net Income | $-39M | $-38M | $-47M | $-44M | $-33M | $-29M | $-22M | $-21M | |
| EPS (Basic) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · | |
| EPS (Diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · | |
| Shares (Basic) | 46,947,932 | 28,526,441 | 22,868,663 | 16,267,678 | 14,473,213 | 12,934,421 | 1,766,412 | · | |
| Shares (Diluted) | 46,947,932 | 28,526,441 | 22,868,663 | 16,267,678 | 14,473,213 | 12,934,421 | 1,766,412 | · | |
| EBITDA | $-34M | $-34M | $-44M | $-39M | $-29M | $-25M | $-19M | · |
Balance Sheet 27
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $53M | $47M | $42M | $44M | $74M | $45M | $17M | |
| Short-term Investments | · | · | · | · | · | $0 | $9M | · | |
| Receivables | $10M | $10M | $10M | $7M | $4M | $3M | $3M | $1M | |
| Inventory | $11M | $13M | $13M | $12M | $8M | $4M | $5M | $4M | |
| Prepaid Expense | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $330.0K | |
| Current Assets | $76M | $78M | $72M | $62M | $59M | $83M | $64M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $626.0K | $677.0K | $758.0K | |
| PP&E (Gross) | $6M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Intangibles | $1M | $2M | $2M | $2M | $2M | $3M | $3M | · | |
| Other Non-current Assets | $500.0K | $2M | · | · | · | · | · | · | |
| Total Assets | $81M | $87M | $78M | $68M | $63M | $86M | $68M | $27M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $2M | $652.0K | $3M | $3M | |
| Accrued Liabilities | $16M | $13M | $15M | $11M | $8M | $6M | $4M | $5M | |
| Current Liabilities | $18M | $16M | $17M | $12M | $11M | $7M | $7M | $10M | |
| Capital Leases | · | $2M | $2M | $1M | · | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $2M | $1M | $380.0K | · | $4.0K | $5.0K | |
| Total Liabilities | $75M | $58M | $59M | $54M | $42M | $37M | $37M | $41M | |
| Long-term Debt | · | $41M | $41M | $40M | $31M | $31M | $30M | · | |
| Total Debt | $56M | $41M | $41M | $40M | · | · | · | · | |
| Common Stock | $44.0K | $39.0K | $24.0K | $19.0K | $15.0K | $14.0K | $11.0K | · | |
| Paid-in Capital | $404M | $387M | $340M | $288M | $250M | $246M | $199M | · | |
| Retained Earnings | $-398M | $-359M | $-321M | $-274M | $-230M | $-197M | $-168M | $-138M | |
| AOCI | $91.0K | $90.0K | $91.0K | $150.0K | $-52.0K | $-71.0K | $-19.0K | · | |
| Stockholders' Equity | $6M | $28M | $19M | $14M | $20M | $49M | $31M | $-138M | |
| Liabilities + Equity | $81M | $87M | $78M | $68M | $63M | $86M | $68M | $27M | |
| Shares Outstanding | 44,538,264 | 39,395,712 | 24,494,675 | 19,165,027 | 14,529,577 | 14,437,107 | 11,406,221 | 295,717 |
Cash Flow 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $4M | $4M | $2M | $457.0K | $216.0K | |
| Deferred Tax | $144.0K | $-144.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $-42M | $-41M | $-41M | $-30M | $-24M | $-26M | $-20M | |
| CapEx | $448.0K | $989.0K | $611.0K | $872.0K | $627.0K | $167.0K | $197.0K | $62.0K | |
| Investing Cash Flow | $846.0K | $4M | $-599.0K | $-2M | $-627.0K | $9M | $-12M | $-2M | |
| Debt Issued | · | · | · | $40M | · | · | · | · | |
| Net Debt Issued | $-42M | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | $46M | $34M | · | $45M | · | · | |
| Net Stock Activity | · | · | $46M | $34M | · | $34.0K | · | · | |
| Financing Cash Flow | $26M | $43M | $46M | $41M | $585.0K | $44M | $66M | $27M | |
| Net Change in Cash | $-2M | $6M | $5M | $-2M | $-30M | $29M | $28M | $6M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-29M | $-43M | $-41M | $-42M | $-31M | $-25M | $-26M | · |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.7% | 67.1% | 68.6% | 65.3% | 63.8% | 61.7% | 60.0% | · | |
| Operating Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | · | |
| Net Margin | -48.4% | -54.6% | -79.8% | -106.9% | -112.9% | -158.1% | -145.2% | · | |
| Pretax Margin | -48.1% | -54.8% | · | · | · | · | · | · | |
| EBITDA Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | · | |
| ROA | -46.2% | -46.0% | -64.0% | -67.9% | -44.7% | -37.3% | -47.1% | · | |
| ROE | -501.1% | -341.1% | -188.8% | -235.6% | -139.2% | -54.7% | 34.6% | · | |
| ROIC | -54.8% | -48.8% | · | · | · | · | · | · |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | 5.0 | 4.2 | 5.0 | 5.6 | 12.6 | 9.6 | · | |
| Quick Ratio | 3.4 | 4.0 | 3.3 | 3.9 | 4.6 | 11.7 | 8.6 | · | |
| Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | · | · | · | · | |
| LT Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | · | · | · | · | |
| Interest Coverage | · | · | -8.4 | -9.6 | -8.2 | -7.1 | -5.3 | · |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.8 | 0.6 | 0.4 | 0.2 | 0.3 | · | |
| Receivables Turnover | 7.9 | 7.0 | 7.1 | 7.6 | 8.5 | 6.6 | 7.5 | · |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.8% | 18.6% | 41.1% | 40.6% | 61.8% | · | · | · | |
| Revenue CAGR 3Y | 24.7% | 33.0% | 47.5% | · | · | · | · | · | |
| Revenue CAGR 5Y | 34.5% | · | · | · | · | · | · | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $80M | $69M | $58M | $41M | $29M | $18M | $15M | · | |
| Net Income TTM | $-39M | $-38M | $-47M | $-44M | $-33M | $-29M | $-22M | · | |
| Market Cap | $53M | $119M | $162M | $220M | $186M | $217M | $148M | · | |
| Enterprise Value | $57M | $107M | $156M | $218M | · | · | · | · | |
| P/E | -1.4 | -2.3 | -3.2 | -4.2 | -5.6 | -6.7 | -0.8 | · | |
| P/S | 0.7 | 1.7 | 2.8 | 5.3 | 6.3 | 11.9 | 9.6 | · | |
| P/B | 8.3 | 4.2 | 8.6 | 15.4 | 9.3 | 4.4 | 4.8 | · | |
| P / Tangible Book | 10.6 | 4.5 | 9.7 | 18.7 | 10.5 | 4.7 | · | · | |
| P / Cash Flow | -1.9 | -2.9 | -4.0 | -5.4 | -6.1 | -8.9 | -5.8 | · | |
| P / FCF | -1.8 | -2.8 | -3.9 | -5.3 | -6.0 | -8.8 | -5.7 | · | |
| EV / EBITDA | -1.7 | -3.1 | -3.5 | -5.6 | · | · | · | · | |
| EV / FCF | -2.0 | -2.5 | -3.8 | -5.2 | · | · | · | · | |
| EV / Revenue | 0.7 | 1.6 | 2.7 | 5.3 | · | · | · | · | |
| Earnings Yield | -70.3% | -44.0% | -30.8% | -23.6% | -18.0% | -14.8% | -132.1% | · |
Income Statement 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $19M | $21M | $21M | $20M | $19M | $18M | $19M | $16M | $17M | $17M | $15M | $14M | $12M | $12M | $11M | |
| Gross Profit | $14M | $13M | $14M | $14M | $14M | $13M | $11M | $13M | $11M | $11M | $12M | $10M | $10M | $8M | $8M | $7M | |
| R&D Expense | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $3M | $2M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $23M | $23M | $20M | $22M | $23M | $23M | $20M | $22M | $23M | $24M | $24M | $21M | $21M | $19M | $18M | $17M | |
| Operating Income | $-9M | $-11M | $-7M | $-8M | $-9M | $-10M | $-8M | $-9M | $-12M | $-5M | $-12M | $-10M | $-10M | $-11M | $-9M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-op | $157.0K | $366.0K | $277.0K | $152.0K | $379.0K | $479.0K | $285.0K | $337.0K | $301.0K | $497.0K | $733.0K | $558.0K | $870.0K | $473.0K | $634.0K | $-195.0K | |
| Pretax Income | $-11M | $-12M | $-9M | $-9M | $-10M | $-11M | $-9M | $-10M | $-13M | $-6M | · | · | · | · | · | · | |
| Income Tax | $60.0K | $60.0K | $145.0K | $0 | $33.0K | $52.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-11M | $-12M | $-9M | $-9M | $-10M | $-11M | $-9M | $-10M | $-13M | $-6M | $-13M | $-11M | $-11M | $-12M | $-10M | $-11M | |
| EPS (Basic) | $-0.20 | $-0.21 | $-0.17 | $-0.19 | $-0.22 | $-0.25 | $-0.17 | $-0.42 | $-0.51 | $-0.23 | $-0.50 | $-0.45 | $-0.46 | $-0.63 | $-0.45 | $-0.64 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $-0.17 | $-0.19 | $-0.22 | $-0.25 | $-0.17 | $-0.42 | $-0.51 | $-0.23 | $-0.50 | $-0.45 | $-0.46 | $-0.63 | $-0.45 | $-0.64 | |
| Shares (Basic) | 57,414,360 | 57,256,518 | -89,106,208 | 45,421,795 | 45,365,325 | 45,267,020 | -45,419,757 | 24,703,578 | 24,663,234 | 24,579,386 | -44,039,884 | 24,483,664 | 23,239,262 | 19,185,621 | -29,587,212 | 16,758,573 | |
| Shares (Diluted) | 57,414,360 | 57,256,518 | -89,106,208 | 45,421,795 | 45,365,325 | 45,267,020 | -45,419,757 | 24,703,578 | 24,663,234 | 24,579,386 | -44,039,884 | 24,483,664 | 23,239,262 | 19,185,621 | -29,587,212 | 16,758,573 | |
| EBITDA | $-9M | $-11M | · | $-8M | $-9M | $-10M | · | $-9M | $-12M | $-5M | · | $-10M | $-10M | $-11M | · | $-9M |
Balance Sheet 26
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $40M | $51M | $30M | $35M | $43M | $53M | $17M | $26M | $37M | · | $58M | $65M | $30M | · | $54M | |
| Receivables | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $11M | $9M | $10M | · | $8M | $8M | $7M | · | $6M | |
| Inventory | $11M | $12M | $11M | $12M | $11M | $14M | $13M | $14M | $13M | $14M | · | $14M | $14M | $15M | · | $12M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Current Assets | $54M | $64M | $76M | $56M | $61M | $70M | $78M | $44M | $51M | $63M | · | $82M | $89M | $54M | · | $74M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Other Non-current Assets | $451.0K | $476.0K | $500.0K | · | $1M | $2M | $2M | $3M | $3M | $3M | · | · | · | · | · | · | |
| Total Assets | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M | $60M | $72M | · | $87M | $94M | $59M | · | $80M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $2M | $4M | $2M | $2M | $2M | $3M | · | $3M | $2M | $5M | · | $5M | |
| Accrued Liabilities | $15M | $14M | $16M | $15M | $14M | $13M | $13M | $14M | $13M | $12M | · | $12M | $11M | $9M | · | $10M | |
| Current Liabilities | $18M | $18M | $18M | $17M | $19M | $17M | $16M | $17M | $15M | $15M | · | $15M | $13M | $14M | · | $15M | |
| Capital Leases | · | · | · | · | · | · | $2M | · | · | · | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $76M | $75M | $75M | $60M | $58M | $59M | $58M | $59M | $57M | $57M | · | $57M | $54M | $56M | · | $56M | |
| Long-term Debt | · | · | · | · | $41M | $41M | · | $41M | $41M | $41M | · | $40M | $40M | $40M | · | $40M | |
| Total Debt | $56M | $56M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | · | $40M | $40M | $40M | · | $40M | |
| Common Stock | $45.0K | $45.0K | $44.0K | $40.0K | $40.0K | $40.0K | $39.0K | $25.0K | $25.0K | $25.0K | · | $24.0K | $24.0K | $19.0K | · | $19.0K | |
| Paid-in Capital | $405M | $405M | $404M | $390M | $389M | $388M | $387M | $343M | $342M | $341M | · | $338M | $337M | $289M | · | $287M | |
| Retained Earnings | $-421M | $-410M | $-398M | $-389M | $-380M | $-370M | $-359M | $-350M | $-339M | $-327M | · | $-308M | $-297M | $-286M | · | $-264M | |
| AOCI | $84.0K | $85.0K | $91.0K | $91.0K | $93.0K | $91.0K | $90.0K | $149.0K | $98.0K | $97.0K | · | $135.0K | $84.0K | $120.0K | · | $262.0K | |
| Stockholders' Equity | $-16M | $-5M | $6M | $2M | $9M | $18M | $28M | $-6M | $3M | $14M | $19M | $31M | $40M | $3M | $14M | $23M | |
| Liabilities + Equity | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M | $60M | $72M | · | $87M | $94M | $59M | · | $80M | |
| Shares Outstanding | 44,833,942 | 44,765,928 | 44,538,264 | 40,341,535 | 39,584,178 | 39,554,771 | 39,395,712 | 24,717,193 | 24,675,832 | 24,653,939 | · | 24,487,578 | 24,475,504 | 19,227,777 | · | 19,159,145 |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $613.0K | $816.0K | $812.0K | $955.0K | $985.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | · | · | $59.0K | $0 | $33.0K | $52.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-11M | $-5M | $-6M | $-8M | $-10M | $-8M | $-9M | $-11M | $-14M | $-11M | $-7M | $-11M | $-12M | $-11M | $-8M | |
| CapEx | $59.0K | $119.0K | $91.0K | $211.0K | $114.0K | $32.0K | $264.0K | $122.0K | $299.0K | $304.0K | $205.0K | $134.0K | $157.0K | $115.0K | $46.0K | $290.0K | |
| Investing Cash Flow | $239.0K | $190.0K | $192.0K | $312.0K | $204.0K | $138.0K | $-190.0K | $-122.0K | $67.0K | $5M | $-193.0K | $-134.0K | $-157.0K | $-115.0K | $-1M | $-290.0K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $-13.0K | · | · | · | · | |
| Financing Cash Flow | $-15.0K | $-298.0K | $26M | $24.0K | $-3.0K | $-116.0K | $43M | $98.0K | $-5.0K | $56.0K | $22.0K | $71.0K | $46M | $-235.0K | $-219.0K | $35M | |
| Net Change in Cash | $-9M | $-11M | $21M | $-5M | $-8M | $-10M | $35M | $-9M | $-11M | $-10M | $-11M | $-7M | $35M | $-12M | $-12M | $27M | |
| Free Cash Flow | · | $-11M | · | · | · | $-10M | · | · | · | $-15M | · | · | · | $-12M | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.3% | 65.7% | · | 67.5% | 69.8% | 67.6% | · | 67.8% | 68.8% | 68.3% | · | 69.0% | 70.4% | 66.3% | · | 65.6% | |
| Operating Margin | -48.1% | -55.2% | · | -36.5% | -45.0% | -56.5% | · | -49.4% | -71.9% | -29.1% | · | -67.6% | -71.5% | -94.5% | · | -85.0% | |
| Net Margin | -58.4% | -64.4% | · | -41.6% | -49.1% | -60.8% | · | -54.7% | -78.3% | -34.1% | · | -72.8% | -74.4% | -101.0% | · | -96.0% | |
| Pretax Margin | -58.1% | -64.1% | · | -41.6% | -49.0% | -60.5% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -48.1% | -55.2% | · | -36.5% | -45.0% | -56.5% | · | -49.4% | -71.9% | -29.1% | · | -67.6% | -71.5% | -94.5% | · | -85.0% | |
| ROA | -17.7% | -16.7% | · | -15.0% | -15.5% | -15.1% | · | -14.8% | -16.3% | -8.7% | · | -13.1% | -14.8% | -21.1% | · | -14.4% | |
| ROE | 337.1% | -190.0% | · | 364.9% | -164.6% | -69.3% | · | -85.4% | -58.8% | -64.6% | · | -40.7% | -56.1% | -182.5% | · | -42.0% | |
| ROIC | -23.2% | -20.9% | · | · | -18.0% | -17.7% | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.6 | · | 3.3 | 3.2 | 4.2 | · | 2.6 | 3.4 | 4.1 | · | 5.4 | 6.8 | 3.7 | · | 4.9 | |
| Quick Ratio | 2.2 | 2.8 | · | 2.4 | 2.4 | 3.2 | · | 1.7 | 2.4 | 3.1 | · | 4.3 | 5.6 | 2.6 | · | 3.9 | |
| Debt / Equity | -3.5 | -10.7 | · | 26.6 | 4.5 | 2.3 | · | -6.5 | 14.2 | 2.8 | · | 1.3 | 1.0 | 12.8 | · | 1.7 | |
| LT Debt / Equity | -3.5 | -10.7 | · | 26.6 | 4.1 | 2.3 | · | -6.5 | 14.2 | 2.8 | · | 1.3 | 1.0 | 12.8 | · | 1.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.6 | · | -7.6 | -8.0 | -9.0 | · | -9.2 |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.8 | 1.9 | · | 1.8 | 2.0 | 1.8 | · | 2.0 | 1.9 | 2.0 | · | 2.2 | 2.2 | 2.2 | · | 2.4 |
Valuation (TTM) 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $79M | $78M | · | $78M | $74M | $70M | · | $67M | $62M | $58M | · | $53M | $48M | $42M | · | $37M | |
| Net Income TTM | $-42M | $-42M | · | $-40M | $-44M | $-40M | · | $-40M | $-40M | $-39M | · | $-44M | $-46M | $-46M | · | $-43M | |
| Market Cap | $34M | $28M | · | $60M | $77M | $48M | · | $63M | $116M | $140M | · | $196M | $248M | $205M | · | $163M | |
| Enterprise Value | $59M | $44M | · | $72M | $83M | $47M | · | $86M | $130M | $143M | · | $178M | $223M | $215M | · | $149M | |
| P/E | -0.9 | -0.7 | · | -1.4 | -1.4 | -0.9 | · | -1.6 | -2.8 | -3.2 | · | -3.7 | -3.9 | -3.7 | · | -3.0 | |
| P/S | 0.4 | 0.4 | · | 0.8 | 1.0 | 0.7 | · | 0.9 | 1.9 | 2.4 | · | 3.7 | 5.2 | 4.9 | · | 4.4 | |
| P/B | -2.1 | -5.3 | · | 38.6 | 8.4 | 2.7 | · | -10.0 | 40.4 | 9.7 | · | 6.4 | 6.2 | 65.1 | · | 7.0 | |
| P / Tangible Book | · | · | · | 583.6 | 10.1 | 2.9 | · | · | 123.2 | 11.3 | · | 6.9 | 6.6 | 277.6 | · | 7.9 | |
| P / Cash Flow | · | -2.5 | · | · | · | -5.0 | · | · | · | -9.7 | · | · | · | -17.7 | · | · | |
| P / FCF | · | -2.5 | · | · | · | -4.9 | · | · | · | -9.5 | · | · | · | -17.5 | · | · | |
| EV / EBITDA | -6.4 | -4.2 | · | -9.5 | -9.2 | -4.5 | · | -9.2 | -11.3 | -29.7 | · | -17.5 | -21.5 | -19.1 | · | -15.7 | |
| EV / FCF | · | -3.9 | · | · | · | -4.8 | · | · | · | -9.8 | · | · | · | -18.4 | · | · | |
| EV / Revenue | 0.7 | 0.6 | · | 0.9 | 1.1 | 0.7 | · | 1.3 | 2.1 | 2.5 | · | 3.4 | 4.6 | 5.1 | · | 4.0 | |
| Earnings Yield | -109.3% | -140.3% | · | -72.5% | -72.2% | -115.6% | · | -63.6% | -35.1% | -31.2% | · | -27.3% | -25.8% | -27.3% | · | -33.3% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $80M | $69M | $58M | $41M | $29M |
| Gross Margin % | 67.7% | 67.1% | 68.6% | 65.3% | 63.8% |
| Operating Margin % | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% |
| Net Income | $-39M | $-38M | $-47M | $-44M | $-33M |
| Diluted EPS | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | — |
| Current Ratio | 4.2 | 5.0 | 4.2 | 5.0 | 5.6 |
| Quick Ratio | 3.4 | 4.0 | 3.3 | 3.9 | 4.6 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-29M | $-43M | $-41M | $-42M | $-31M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 46 filers · $19.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 13 (+12 vs prior Q) | 1 (-8 vs prior Q) | 9 (-3 vs prior Q) | 9 (+4 vs prior Q) | -65K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | $5,786,032 | 7,714,709 | 30.04% | Shares |
| Nantahala Capital Management, LLC | $4,420,586 | 5,894,114 | 22.95% | Shares |
| Stonepine Capital Management, LLC | $1,996,820 | 2,662,427 | 10.37% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1,602,901 | 2,137,201 | 8.32% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,176,164 | 1,568,218 | 6.11% | Shares |
| DAFNA Capital Management LLC | $1,080,772 | 1,441,029 | 5.61% | Shares |
| PERKINS CAPITAL MANAGEMENT INC | $1,031,281 | 1,375,042 | 5.35% | Shares |
| Sio Capital Management, LLC | $477,225 | 636,300 | 2.48% | Shares |
| WealthTrust Axiom LLC | $343,300 | 457,734 | 1.78% | Shares |
| VANGUARD GROUP INC | $249,761 | 211,662 | 1.30% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $243,264 | 324,305 | 1.26% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $159,854 | 213,138 | 0.83% | Shares |
| UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC | $91,398 | 99,888 | 0.47% | Shares |
| Embree Financial Group | $68,180 | 90,906 | 0.35% | Shares |
| BlackRock, Inc. | $63,547 | 84,729 | 0.33% | Shares |
| NORTHERN TRUST CORP | $56,093 | 74,790 | 0.29% | Shares |
| STATE STREET CORP | $47,537 | 63,383 | 0.25% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $43,575 | 58,100 | 0.23% | Shares |
| PNC Financial Services Group, Inc. | $40,209 | 53,612 | 0.21% | Shares |
| Destiny Wealth Partners, LLC | $38,320 | 52,500 | 0.20% | Shares |
| Ducere Wealth Management LLC | $38,250 | 51,000 | 0.20% | Shares |
| JANE STREET GROUP, LLC | $26,470 | 35,294 | 0.14% | Shares |
| UBS Group AG | $25,100 | 33,466 | 0.13% | Shares |
| XTX Topco Ltd | $22,169 | 29,558 | 0.12% | Shares |
| TD Waterhouse Canada Inc. | $16,560 | 23,000 | 0.09% | Shares |
| PRIMORIS WEALTH ADVISORS, LLC | $15,225 | 20,300 | 0.08% | Shares |
| RAYMOND JAMES FINANCIAL INC | $15,000 | 20,000 | 0.08% | Shares |
| GREAT VALLEY ADVISOR GROUP, INC. | $14,702 | 19,602 | 0.08% | Shares |
| J.W. COLE ADVISORS, INC. | $12,188 | 16,250 | 0.06% | Shares |
| Atom Investors LP | $11,605 | 15,473 | 0.06% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $11,121 | 14,828 | 0.06% | Shares |
| HighTower Advisors, LLC | $8,400 | 11,200 | 0.04% | Shares |
| GOLDMAN SACHS GROUP INC | $7,787 | 10,383 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $7,691 | 10,255 | 0.04% | Shares |
| Vanguard Global Advisers, LLC | $3,453 | 4,604 | 0.02% | Shares |
| WELLS FARGO & COMPANY/MN | $3,150 | 4,200 | 0.02% | Shares |
| Steward Partners Investment Advisory, LLC | $1,493 | 1,991 | 0.01% | Shares |
| CITIGROUP INC | $1,331 | 1,774 | 0.01% | Shares |
| SIMPLEX TRADING, LLC | $957 | 1,276 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $226 | 301 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $158 | 210 | 0.00% | Shares |
| BARCLAYS PLC | $156 | 208 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $75 | 100 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $28 | 39 | 0.00% | Shares |
| MORGAN STANLEY | $28 | 37 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 59 | 0.00% | Shares |
Company insiders 26 insiders · 10 officers · 16 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Antony Koblish | Chief Executive Officer | Feb. 20, 2026 A | 586,210 | 0 | 0 | $0 |
| Roberto Cuca | COO and CFO | Feb. 21, 2025 A | 208,233 | 0 | 0 | $0 |
| Nora Brennan | Chief Financial Officer | March 31, 2021 A | 17,696 | 0 | 0 | $0 |
| Jeffrey Blizard | President | June 2, 2025 A | 119,125 | 0 | 0 | $0 |
| Gregory A. Firestone | Chief Commercial Officer | Aug. 3, 2025 F | 106,790 | 0 | 0 | $0 |
| Megan Smeykal | Chief Accounting Officer | March 31, 2025 F | 36,831 | 0 | 0 | $0 |
| Paul Talmo | Chief Technology Officer | March 31, 2025 F | 123,882 | 0 | 0 | $0 |
| Peter C. Murphy | Chief Commercial Officer | March 31, 2024 F | 48,129 | 0 | 0 | $0 |
| Ellis Skott Greenhalgh | Chief Technology Officer | Feb. 24, 2022 F | 27,826 | 0 | 0 | $0 |
| Maarten Persenaire | Chief Medical Officer | Feb. 24, 2021 A | 90,887 | 0 | 0 | $0 |
| William J. Plovanic | Director | July 15, 2026 A | 44,530 | 0 | 0 | $0 |
| Joseph H Capper | Director | July 15, 2026 A | 29,827 | 0 | 0 | $0 |
| Betty Jo Rocchio | Director | June 9, 2026 A | 23,600 | 0 | 0 | $0 |
| Guido J Neels | Director | June 9, 2026 A | 23,600 | 0 | 0 | $0 |
| Guy P Nohra | Director | June 9, 2026 A | 23,600 | 0 | 0 | $0 |
| Paul Thomas | Director | June 9, 2026 A | 23,600 | 0 | 0 | $0 |
| Kurt Azarbarzin | Director | May 28, 2025 A | 18,470 | 0 | 0 | $0 |
| Vincent J Burgess | Director | May 28, 2025 A | 23,330 | 0 | 0 | $0 |
| Douglas G Evans | Director | May 28, 2025 A | 18,470 | 0 | 0 | $0 |
| Lisa N Colleran | Director | May 28, 2025 A | 18,470 | 0 | 0 | $0 |
| Federica F. O'Brien | Director | May 28, 2025 A | 18,470 | 0 | 0 | $0 |
| John Nosenzo | Director | June 1, 2023 A | 6,270 | 0 | 0 | $0 |
| Adele C Oliva | Director | June 4, 2020 A | 1,751,100 | 0 | 0 | $0 |
| Matt Zuga | Director | Nov. 13, 2019 C | 498,606 | 0 | 0 | $0 |
| Ashley Friedman | Director | Nov. 13, 2019 C | 505,281 | 0 | 0 | $0 |
| Heather C Getz | — | Aug. 14, 2026 P | 520,000 | 1 | 0 | $10,500 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| EW HEALTHCARE PARTNERS FUND 2, L.P., EW HEALTHCARE PARTNERS FUND 2-A, L.P., EW Healthcare Partners Fund 2-GP, L.P., EW Healthcare Partners Fund 2-UGP, LLC ×5 filings | June 9, 2026 | 17.23% | Initial filing | Board campaign | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×7 filings | Oct. 25, 2024 | — | Initial filing | — | SEC |
| Undisclosed reporting person | June 10, 2022 | — | Initial filing | — | SEC |
| EW Healthcare Partners 2, L.P., EW Healthcare Partners Fund 2-A, L.P., EW Healthcare Partners Fund 2-UGP, LLC, EW Healthcare Partners Fund 2 GP, L.P., Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio ×4 filings | June 1, 2022 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.